JP Morgan Chase’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VPC
EP
VCM
YCM
IC
EAM
JP Morgan Chase's PASG Position: Q1 2026 in Review
JP Morgan Chase held its Passage Bio (PASG) position steady in Q1 2026 at 15 shares worth $93. The position accounts for ﹤0.01% of the portfolio, ranked #7317.
JP Morgan Chase first reported a position in PASG in Q2 2020 and has held it in 24 quarters since. The position peaked at $10.2M in Q2 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.
- JP Morgan Chase held 15 shares of Passage Bio worth $93 as of Q1 2026.
- JP Morgan Chase left its Passage Bio share count unchanged in Q1 2026.
- Passage Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7317 holding.
- JP Morgan Chase first reported a position in Passage Bio in Q2 2020 and has held it in 24 quarters since.
- JP Morgan Chase's Passage Bio position peaked at $10.2M in Q2 2021.
- 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.